Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Proteinuria and VEGF[original query] |
|---|
| Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004 Mar 53 (3): 861-4. Ray David, Mishra Manoj, Ralph Shirley, Read Ian, Davies Robert, Brenchley Pa |
| Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Molecular human reproduction 2006 Apr 12 (4): 233-6. Bányász Ilona, Szabó Szilvia, Bokodi Géza, Vannay Adám, Vásárhelyi Barna, Szabó András, Tulassay Tivadar, Rigó Ján |
| Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy. Renal failure 2006 28 (1): 15-20. Chow Kai Ming, Szeto Cheuk Chun, Lai Fernand Mac-Moune, Poon Peter, Wong Teresa Yuk-Hwa, Li Philip Kam-T |
| Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology (Carlton, Vic.) 2009 Oct 14 (7): 681-8. Kim Hye Won, Ko Gang Jee, Kang Young Sun, Lee Mi Hwa, Song Hye Kyoung, Kim Hyoung Kyu, Cha Dae Ryo |
| The association between therapeutic outcomes and VEGF G-1154A and C-936T gene polymorphisms in patients with glomerulonephritis. Renal failure 2014 Jul 36 (6): 904-7. Terzi Hatice, Kayatas Mansur, Korkmaz Serdal, Yildiz Gürsel, Candan Ferh |
| A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A. Lung cancer (Amsterdam, Netherlands) 2016 Sep 99 131-6. Usui Kazuhiro, Sugawara Shunichi, Nishitsuji Masaru, Fujita Yuka, Inoue Akira, Mouri Atsuto, Watanabe Hiroshi, Sakai Hiroshi, Kinoshita Ichiro, Ohhara Yoshihito, Maemondo Makoto, Kagamu Hiroshi, Hagiwara Koichi, Kobayashi Kunihiko, |
| Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials. European journal of cancer (Oxford, England : 1990) 2017 Mar 77 13-20. Berger Martin D, Yamauchi Shinichi, Cao Shu, Hanna Diana L, Sunakawa Yu, Schirripa Marta, Matsusaka Satoshi, Yang Dongyun, Groshen Susan, Zhang Wu, Ning Yan, Okazaki Satoshi, Miyamoto Yuji, Suenaga Mitsukuni, Lonardi Sara, Cremolini Chiara, Falcone Alfredo, Heinemann Volker, Loupakis Fotios, Stintzing Sebastian, Lenz Heinz-Jos |
| Genetic predisposition to bevacizumab-induced hypertension. Gynecologic oncology 2017 Sep . Frey Melissa K, Dao Fanny, Olvera Narciso, Konner Jason A, Dickler Maura N, Levine Douglas |
| Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study. Frontiers in molecular biosciences 2021 5 8 639892. Yang Xue, Xia Yang, Xu Liyan, Liang Li, Zhuo Minglei, Wu Meina, An Tongtong, Wang Ziping, Wang Yuyan, Li Jianjie, Zhong Jia, Chen Hanxiao, Jia Bo, Wang Jingjing, Zhao J |
| Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2229-2236. Lee Sunyoung, Shroff Rachna T, Makawita Shalini, Xiao Lianchun, Danner De Armas Anaemy, Bhosale Priya, Reddy Kavitha, Shalaby Ahmed, Raghav Kanwal, Pant Shubham, Wolff Robert A, Javle Mili |
| Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective study. American journal of cancer research 2022 1 11 (12): 6107-6118. Xue Miao, Wu Yanqin, Zhu Bowen, Zou Xinhua, Fan Wenzhe, Li Jiapi |
- Page last reviewed:Feb 1, 2024
- Content source: